Develop scalable inactivation

Ended Purchase Order Awarded Last action

Contract number
HHSD2002016M92103P
Awardee
Awarding agency
Obligated
$149,748

Award facts

Opportunity
  • 2016Q66046 Solicitation number
Contract value 100% obligated
$149,748.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
R499 Support- Professional: Other
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Atlanta, GA 30329, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

This contract was awarded by the Centers for Disease Control and Prevention (CDC) to Meridian Life Science Inc., a small disadvantaged business, to develop scalable inactivation capabilities. The firm-fixed price purchase order, valued at $149,748.00, was awarded on September 1, 2016, with a completion date of March 31, 2017. The contract did not have a set-aside designation. Without additional information on the original solicitation, the specific products or services to be delivered under this contract are unclear.

Quick answers

Who was awarded contract HHSD2002016M92103P?

HHSD2002016M92103P was awarded to Meridian Life Science Inc. by CDC Pittsburgh (Centers for Disease Control and Prevention) on September 1, 2016.

How much is contract HHSD2002016M92103P worth?

The government has obligated $149,748 on HHSD2002016M92103P.

Was contract HHSD2002016M92103P competed?

The extent of competition for HHSD2002016M92103P was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login